Lorlatinib Should Not be Considered as the Preferred First-Line Option in Patients With Advanced ALK Rearranged NSCLC
David Ross Camidge
Topics & Concepts
MedicineLine (geometry)OncologyInternal medicineFirst lineGeometryMathematicsLung Cancer Treatments and MutationsLung Cancer Research StudiesLung Cancer Diagnosis and Treatment